Registry and Biorepository for the Study of Inflammatory Bowel Diseases in Central Texas
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Crohn Disease
- Sponsor
- University of Texas at Austin
- Enrollment
- 1000
- Locations
- 1
- Primary Endpoint
- Number of patients with inflammatory bowel disease
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples, tissue samples, and fecal samples for research purposes, while the participants are undergoing a clinically-indicated procedure (i.e. venipuncture for routine tests, IV catheter placement, and/or endoscopy). Participants may choose to provide any or all of the aforementioned information and/or samples.
Investigators
Linda Anne Feagins, MD
Associate Professor of Medicine
University of Texas at Austin
Eligibility Criteria
Inclusion Criteria
- •Male or female, age 18 years or older
- •Willing and able to provide written consent for participation in the registry and biorepository
- •Patients with known or suspected inflammatory bowel disease
Exclusion Criteria
- •Patient is unable to comprehend and/or cooperate with study activities
- •Patient is too ill to provide consent
- •Coagulopathy that precludes safe biopsy of the bowel
- •Comorbidity that precludes safe participation in endoscopic procedures
Outcomes
Primary Outcomes
Number of patients with inflammatory bowel disease
Time Frame: 10 YEARS
Number of patients with Crohns, ulcerative colitis, and IBD undetermined